Coronary patency, infarct size and left ventricular function after thrombolytic therapy for acute myocardial infarction: results from the tissue plasminogen activator: Toronto (TPAT) placebo-controlled trial. TPAT Study Group

Sunnybrook Health Science Centre, Toronto, Ontario, Canada.

Infarct size, left ventricular function and infarct-related coronary artery patency were examined in 108 patients who took part in a previously reported placebo-controlled trial of recombinant tissue-type plasminogen activator (rt-PA) in acute myocardial infarction. Coronary angiography was performed 17 +/- 0.8 h after initiation of treatment in 47 patients (group A) or at 10 days in 61 patients (group B). Both groups underwent radionuclide ventriculography 3.8 +/- 0.8 h and again on day 9 after treatment and quantitative thallium scintigraphy on day 8. In group A, the infarct-related artery was patent in 53%; these patients had a smaller global (15.1 +/- 2.5% vs. 25.7 +/- 4.7%, p = 0.029) and regional (14.7 +/- 2.5% vs. 24.1 +/- 4.7%, p = 0.044) fixed thallium defect than did those with an occluded artery. Infarct regional ejection fraction improved by 10.1 +/- 2.1% between early and late studies when the infarct-related artery was patent and by 4.8 +/- 1.4% if it was occluded (p = 0.048); changes in global and noninfarct regional ejection fraction were similar irrespective of perfusion status. Infarct regional ejection fraction and fixed thallium defect were inversely related only when the infarct-related artery was occluded (r = -0.83, p less than 0.0001). In group B, 10 day patency of the infarct-related artery was 67%; there was no difference in patency by treatment assignment or in left ventricular function or infarct size between patients with and without infarct-related artery patency. There was no evidence of an effect of rt-PA therapy beyond that expressed through coronary patency alone in either group A or group B.

This article has been cited by other articles:

				B. A. Davis, C. O'Sullivan, P. H. Jarritt, and J. B. Porter Value of sequential monitoring of left ventricular ejection fraction in the management of thalassemia major Blood, July 1, 2004; 104(1): 263 - 269. [Abstract] [Full Text] [PDF]

				I Ikonomidis, G Athanassopoulos, G Karatasakis, A.S Manolis, M Marinou, A Economou, and D.V Cokkinos Dispersion of ventricular repolarization is determined by the presence of myocardial viability in patients with old myocardial infarction. A dobutamine stress echocardiography study Eur. Heart J., March 2, 2000; 21(6): 446 - 456. [Abstract] [PDF]

				A. M. Ross, K. S. Coyne, J. S. Reiner, S. W. Greenhouse, C. Fink, A. Frey, E. Moreyra, M. Traboulsi, N. Racine, A. L. Riba, et al. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial J. Am. Coll. Cardiol., December 1, 1999; 34(7): 1954 - 1962. [Abstract] [Full Text] [PDF]

				C. A. Schneider, E. Voth, F. M. Baer, M. Horst, R. Wagner, and U. Sechtem QT Dispersion Is Determined by the Extent of Viable Myocardium in Patients With Chronic Q-Wave Myocardial Infarction Circulation, December 2, 1997; 96(11): 3913 - 3920. [Abstract] [Full Text]

				K.M.A. Hussain, L. Gould, B. Sosler, T. Bharathan, and C.V.R. Reddy Clinical Science Review: Current Aspects of Thrombolytic Therapy in Women with Acute Myocardial Infarction Angiology, January 1, 1996; 47(1): 23 - 33. [Abstract] [PDF]

				G. A. Lamas, G. C. Flaker, G. Mitchell, S. C. Smith Jr, B. J. Gersh, C.-C. Wun, L. Moye, J. L. Rouleau, J. D. Rutherford, M. A. Pfeffer, et al. Effect of Infarct Artery Patency on Prognosis After Acute Myocardial Infarction Circulation, September 1, 1995; 92(5): 1101 - 1109. [Abstract] [Full Text]

				T. Brzostek, F. Van de Werf, I. Scheys, L. Mortelmans, A. Aubert, J. S. Dubiel, and H. De Geest Determinants of Left Ventricular Function Two Weeks and One Year After an Acute Myocardial Infarction Angiology, January 1, 1995; 46(1): 27 - 36. [Abstract] [PDF]

				A D Flapan Fortnightly Review: Management of patients after their first myocardial infarction BMJ, October 29, 1994; 309(6962): 1129 - 1134. [Full Text]

				The GUSTO Angiographic Investigators The Effects of Tissue Plasminogen Activator, Streptokinase, or Both on Coronary-Artery Patency, Ventricular Function, and Survival after Acute Myocardial Infarction N. Engl. J. Med., November 25, 1993; 329(22): 1615 - 1622. [Abstract] [Full Text]